Water Island Capital’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Water Island Capital’s Portfolio PRVL Stock Details PRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-94,608	Closed	-$2.18M	–	139
2020 Q4	$2.18M	Buy	+94,608	New	+$1.2M	0.15%	43

Water Island Capital's PRVL Position: Q1 2021 in Review

Water Island Capital sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 94,608 shares — an estimated $2.18M sold.

Water Island Capital first reported a position in PRVL in Q4 2020 and held it in 1 quarter. The position peaked at $2.18M in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

Water Island Capital reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Water Island Capital sold 94,608 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $2.18M.
Water Island Capital first reported a position in Prevail Therapeutics Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Water Island Capital's Prevail Therapeutics Inc. Common Stock position peaked at $2.18M in Q4 2020.
0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on Water Island Capital's 13F filing for Q1 2021, filed 13 May 2021.